(Q45012920)

8 December 2017

Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture (English)

1 reference

8 December 2017

0 references

0 references

1 reference

Kamel HK

1

1 reference

8 December 2017

Hussain MS

2

1 reference

8 December 2017

Tariq S

3

1 reference

8 December 2017

Perry HM

4

1 reference

8 December 2017

Morley JE

5

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

American Journal of Medicine

8 December 2017

1 reference

8 December 2017

109

1 reference

8 December 2017

4

1 reference

8 December 2017

326-328

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

8 December 2017

1 reference

Age-related osteoporosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Consensus development conference: prophylaxis and treatment of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Occult vitamin D deficiency in postmenopausal US women with acute hip fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Correcting calcium nutritional deficiency prevents spine fractures in elderly women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Vitamin D3 and calcium to prevent hip fractures in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Meta-analysis of prevention of nonvertebral fractures by alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

HRT and the risk of deep vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Osteoporosis and osteopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Bone density and risk of hip fracture in men and women: cross sectional analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

New drugs--reports of new drugs recently approved by the FDA. Alendronate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900457-5

10.1016/S0002-9343(00)00457-5

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference